- Ion Beam Applications developed a new super conducting accelerator for Proteus One, an intensity modulated proton therapy system used to treat patients with cancer.
- Troxyca, developed by New York City-based Pfizer, is an opioid painkiller that contains abuse-deterrent features.
- The ImPACT device is used to assess cognitive function following possible concussion or brain injury.
- Telmisartan tablets are intended to treat patients with hypertension.
- Oculus Innovative Sciences created a new post-dermal procedure product used to remove foreign materials like microorganisms and debris from a wound following dermal procedures.
More articles on supply chain:
11 drugmakers with the highest profit margins
Supply chain tip of the week: How to engage physicians in the decision-making process
Hillary Clinton calls on Mylan to lower EpiPen prices
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.